Archives

Filter 

Newsletter

BioMedReports Active Stocks: Amgen, Alkermes, Nanosphere, Biogen Idec, Regulus Therapeutics: U.S. stocks turned lower in af... http://t.co/gHIHogcGHP
30mreplyretweetfavorite
BioMedReports Agios Pharma Reports Initiation of Phase 1/2 Clinical Trial of AG-221; Pluristem Advances its Second Major Cel... http://t.co/qkvJGEUaT5
24hreplyretweetfavorite
BioMedReports Active Stocks: MELA Sciences, Synergy Pharmaceuticals, Omeros, Novartis, Enanta Pharmaceuticals: U.S. stocks ... http://t.co/HvHIdi6Bgg
navigation
Benzinga.com supporter Seeking Alpha Certified